Description: Reactivating Pathways to Healing Caeregen Therapeutics discovers and develops novel therapies which repair, restore, and protect damaged and diseased tissues by reactivating the pathways and signaling which accompany normal cellular and tissue development. Our revolutionary regenerative medicine approaches have the potential to restore lost or degraded functioning to diseased tissue and organs. Learn More
regenerative medicine (211) retinal (35) vision loss (21) rvo (12) fevr (5) retinal disease (2) caeregen therapeutics (1) familial exudative vitreoretinopathy (1) norrin (1) vein occlusion (1)
Caeregen Therapeutics discovers and develops novel therapies which repair, restore, and protect damaged and diseased tissues by reactivating the pathways and signaling which accompany normal cellular and tissue development. Our revolutionary regenerative medicine approaches have the potential to restore lost or degraded functioning to diseased tissue and organs.
As a company dedicated to pursuit of regenerative medicine approaches for sensory-related diseases, Caeregen Therapeutics applies leading-edge science and technologies to the discovery and development of novel therapies to repair, restore, and protect diseased or damaged sensory and neurologic structures. We are a pre-clinical company advancing one of our first discoveries, Noregen™ (CTR-107), a synthetic protein modeled after human norrin, a naturally occurring protein that guides retinal vascular formatio
Supporting the body in repairing damaged cells